Healthequity Inc (HQY) Institutional Buying & Selling Tracker (Q2 2026)

HQY ranks #1181 out of 37503 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

HQY is a top-conviction position for Greenhouse Funds LLLP — at 5.5% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in HQY belongs to BlackRock, Inc., but the position matters far more to Greenhouse Funds LLLP, who has 5.5% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Morgan Stanley has added to its HQY position for two straight quarters, increasing it by $274.6M to reach $410.7M today.

Israel Englander has trimmed its HQY position for two straight quarters, cutting it by $64.6M while still holding $22.6M.

HQY is up 1.6% today, and institutions have been net buyers of $1.4B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

HQY posted net income of $236.5M over the trailing twelve months, and currently trades at a P/E of 36.4.

• Profitable — net income of $236.5M over the trailing twelve months
• Revenue grew 7.3% year over year
• Net income improved year over year, from $145.8M to $236.5M
• Generated $457.1M in positive operating cash flow
• Current ratio of 3.27x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.60x equity — within a conventional range